Phase 2 Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are able to understand and willing to sign a consent form agreeing to take part in the study.
- You are between 18 and 80 years old.
- You are able to carry out basic daily activities and care for yourself, with at most some limitations (confirm with trial site).
- Your cancer has been confirmed by a tissue or cell sample to be a specific type of pancreatic cancer called adenocarcinoma.
- Your pancreatic cancer is in its original location and you have not yet received major cancer treatments.
- Your cancer has either spread to nearby tissues and cannot be removed by surgery, or has spread to other parts of the body.
- You have at least one tumour that can be measured on a scan, according to standard measurement guidelines.
- Your doctor expects you to live for at least 3 months.
- Your liver, kidneys, and other organs are working well enough, based on blood test results.
- You are willing and able to follow the study schedule and procedures.
Who may not be able to join:
- You are pregnant or currently breastfeeding.
- You have already received chemotherapy, radiotherapy, or other cancer treatments.
- Your pathology (tissue test) results show your cancer is not the adenocarcinoma type of pancreatic cancer.
- You have inflammation in your digestive system, such as pancreatitis, gallbladder inflammation, or bile duct inflammation.
- You have serious ongoing health conditions that are not well controlled and could affect how the study is run or its results.
- You have had a heart attack, stroke, or similar cardiovascular or brain-related event (confirm with trial site).
- You are allergic to the medicines being used in this trial.
- You have other serious health problems that, in the doctor's opinion, could make the treatment unsafe for you.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 86 64175590
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall survival，OS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.